Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

JQC vs JRS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JRS Captures Overall Composite Edge (38.1 SELL vs 39.9 SELL), While JQC Leads 1–0 on Growth & Valuation Pillars

JRS Overall Winner 6-Pillar Tally: JQC 1 – 0 JRS (5 Tie) Matrix Metrics: JQC 3 – 1 JRS

As of Nov 16, 2026, Nuveen Real Estate Income Fund (JRS) captures the overall head-to-head institutional edge over Nuveen Credit Strategies Income Fund (JQC) on higher Unified Composite conviction (38.1/100 SELL vs. 39.9/100 SELL) after splitting the core matrix 1–3 (led by composite factor balance), while JQC wins 1–0 across the 6-pillar growth and valuation breakdown. JQC trades at $4.53 (N/M Forward P/E, N/A operating margin) versus JRS at $7.59 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While JQC currently prints a higher short-term Unified Composite Score (39.9/100 SELL vs. JRS 38.1/100 SELL), JRS captures the overall institutional head-to-head verdict (1–3 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
  • Defensive Composite Rating Caution: Although JRS compares more favorably head-to-head, both JQC (39.9/100 SELL) and JRS (38.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: JQC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6); meanwhile JRS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About JQC vs JRS
JQC NYSE
Nuveen Credit Strategies Income Fund
Institutional Equity
$4.53
+0.0% 1D
Market Cap $732.1M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.33β · 17% Vol
Unified Composite Score
39.9 / 100 SELL
Tech 48.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.9%) with fading momentum, RSI 44
RSI-14: 43.6 · SMA20: $4.56 · SMA50: $4.61
JRS NYSE Head-to-Head Winner
Nuveen Real Estate Income Fund
Institutional Equity
$7.59
-0.78% 1D
Market Cap $236.9M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.48β · 19% Vol
Unified Composite Score
38.1 / 100 SELL
Tech 48.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 52.1 · SMA20: $7.55 · SMA50: $7.53

6-Pillar Scorecard Institutional Category Breakdown (JQC 1 – 0 JRS)

Columns: Metric · JQC · JRS
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale JQC
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $732.1M $236.9M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: JQC (3) vs JRS (1)
Institutional Metric JQC JRS Criterion Row Edge
Market Capitalization
Scale
$732.1M $236.9M Larger Scale JQC
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
11% ($4–$5) 27% ($7–$9) Stronger Trend JRS
Beta / 30D Volatility
Risk Regime
0.33β · 17% Vol 0.48β · 19% Vol Lower Realized Risk JQC
Unified Institutional Score
Composite Signal
39.9 / 100 (SELL) 38.1 / 100 (SELL) Higher Composite JQC
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JRS +3.28 pp
JQC: +1.12% · JRS: +4.4%
3M Horizon JQC +5.35 pp
JQC: -4.83% · JRS: -10.18%
6M Horizon JQC +0.13 pp
JQC: -5.23% · JRS: -5.36%
1Y Horizon JRS +6.77 pp
JQC: -11.18% · JRS: -4.41%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JQC vs JRS. Trailing 12-month operating profitability (JQC N/A vs JRS N/A) and valuation multiples (JQC N/M vs JRS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

JQC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
JRS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
JQC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact JQC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JRS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact JRS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
JQC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $732.1M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
JRS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $236.9M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ JQC vs JRS Key Questions & Quantitative Answers

As of Nov 16, 2026, Nuveen Real Estate Income Fund (JRS) captures the overall head-to-head institutional edge over Nuveen Credit Strategies Income Fund (JQC) on higher Unified Composite conviction (38.1/100 SELL vs. 39.9/100 SELL) after splitting the core matrix 1–3 (led by composite factor balance), while JQC wins 1–0 across the 6-pillar growth and valuation breakdown. JQC trades at $4.53 (N/M Forward P/E, N/A operating margin) versus JRS at $7.59 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While JQC currently prints a higher short-term Unified Composite Score (39.9/100 SELL vs. JRS 38.1/100 SELL), JRS captures the overall institutional head-to-head verdict (1–3 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Defensive Composite Rating Caution: Although JRS compares more favorably head-to-head, both JQC (39.9/100 SELL) and JRS (38.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: JQC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.6); meanwhile JRS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 52.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

JQC leads the Growth & Scale pillar: JQC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with JRS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JQC generates N/A in USD-normalized revenue versus N/A for JRS. In operating R&D and SG&A reinvestment, JQC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for JRS.

JQC and JRS trade at balanced relative valuation multiples. JQC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas JRS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JQC (N/A ROE) versus JRS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, JQC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.33β · 17% Vol realized risk). By comparison, JRS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.48β · 19% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.